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Abstract 
Radiomic features achieve promising results in cancer diagnosis, treatment response prediction, 
and survival prediction. Our goal is to compare the handcrafted (explicitly designed) and deep 
learning (DL)-based radiomic features extracted from pre-treatment diffusion-weighted magnetic 
resonance images (DWIs) for predicting neoadjuvant chemoradiation treatment (nCRT) response 
in patients with locally advanced rectal cancer (LARC). 43 patients receiving nCRT were included. 
All patients underwent DWIs before nCRT and total mesorectal excision surgery 6-12 weeks after 
completion of nCRT. Gross tumor volume (GTV) contours were drawn by an experienced 
radiation oncologist on DWIs. The patient-cohort was split into the responder group (n=22) and 
the non-responder group (n=21) based on the post-nCRT response assessed by postoperative 
pathology, MRI or colonoscopy. Handcrafted and DL-based features were extracted from the 
apparent diffusion coefficient (ADC) map of the DWI using conventional computer-aided 
diagnosis methods and a pre-trained convolution neural network, respectively. Least absolute 
shrinkage and selection operator (LASSO)-logistic regression models were constructed using 
extracted features for predicting treatment response. The model performance was evaluated with 
repeated 20 times stratified 4-fold cross-validation using receiver operating characteristic (ROC) 
curves and compared using the corrected resampled t-test. The model built with handcrafted 
features achieved the mean area under the ROC curve (AUC) of 0.64, while the one built with DL-
based features yielded the mean AUC of 0.73. The corrected resampled t-test on AUC showed P-
value < 0.05. DL-based features extracted from pre-treatment DWIs achieved significantly better 
classification performance compared with handcrafted features for predicting nCRT response in 
patients with LARC.  
 
Keywords: Deep learning, Radiomics, Treatment response prediction  
1. Introduction 
Colorectal cancer is the third most common cancer diagnosed and the second most common cause 
of cancer deaths in the US [1]. Rectal cancer accounts for about 30% of all colorectal cancer 
diagnoses [1]. Treatment for rectal cancer is based largely on the stage at diagnosis. Locally 
advanced rectal cancer (LARC) is commonly treated with neoadjuvant chemoradiation therapy 
(nCRT) followed by total mesorectal excision (TME) and adjuvant chemotherapy[2,3]. Tumor 
response to nCRT is associated with recurrence and survival and can serve as a prognostic factor 
[4,5]. 15-27% of patients who undergo such treatment achieve pathologic complete response (pCR) 
[6]. TME is a highly invasive procedure with the potential risk of morbidity and functional 
complications. Achieving early prediction of tumor response using noninvasive approaches may 
allow for individualized patient management and potential avoidance of TME following nCRT.  
Magnetic resonance imaging (MRI) is widely used in rectal cancer diagnosis and staging 
as it provides excellent soft tissue contrast for tissue characterization. Specifically, increasing 
evidence has shown that diffusion-weighted images (DWIs), providing tissue cellularity 
information, aids the assessment of rectal cancer response to neoadjuvant treatment [7]. DWI is 
recommended to be routinely acquired in clinical guidelines [8]. The interpretation of DWI has 
gradually shifted from qualitative evaluation to quantitative assessment. For example, the apparent 
diffusion coefficient (ADC) map was one major quantitative map calculated from DWI. However, 
several studies showed that the mean pretreatment tumor ADC value was not a reliable indicator 
for predicting treatment response [9,10].   
 Radiomics is an emerging field of studies where a large number of medical image features 
are extracted in order to achieve better clinical diagnosis or decision support [11]. The 
conventional radiomics analysis typically involves extraction and analyzing quantitative imaging 
features from the previously defined region of interests (ROI) on one or multiple image modalities 
with the ultimate goal to obtain predictive or prognostic models. Previous studies showed that 
handcrafted, or explicitly designed, features extracted from the ADC ROI have predictive power 
for early nCRT treatment response in LARC patients [12,13]. However, handcrafted features are 
lower-order image features and limited to current expert knowledge. Another type of radiomic 
feature is deep learning (DL)-based extracted from the pre-trained convolutional neural networks 
(CNN) via transfer learning [14,15]. Several studies have demonstrated that the DL-based features 
showed promising performance in breast cancer diagnosis, ovarian cancer recurrence prediction, 
and glioblastoma multiforme survival prediction [16–18]. To our knowledge, no published study 
has investigated the DL-based features for managing LARC patients.  
In this work, we first aimed to construct radiomics classifiers based on the handcrafted and 
DL-based radiomic features extracted from pre-treatment DWIs. Then, we compared the 
performance of the two classifiers to predict post-nCRT response in patients with LARC.  
 
2. Materials and methods  
2.1. Dataset 
We identified forty-three consecutive patients with locally advanced rectal cancer (LARC) treated 
from December 2015 to December 2016 at a single institution. All patients received concurrent 
capecitabine with a total prescription dose of 50 Gy in 25 fractions, followed by the TME surgery 
after 6-12 weeks of the nCRT completion. The resection specimens were evaluated by an expert 
pathologist. Patients were separated into good responders (GR) and non-GR groups based on the 
postoperative pathology report, MRI or colonoscopy. The GR group consisted of patients with 
either complete response (evaluated by pathology or MRI and colonoscopy) or partial response 
(assessed by pathology), and the non-GR group consisted of patients with stable disease (assessed 
by pathology) and progressive disease (confirmed by CT/MR). 
All patients underwent pre-treatment DWIs before the nCRT. The DWI images were 
acquired using single-shot echo planar imaging (ssEPI) sequence on two 3-Tesla MR scanners. 
MR imaging parameters are summarized in Table 1. For each patient, the ADC map was computed 
using the equation 𝐴𝐷𝐶 = −
1
800
ln(
𝑆
𝑆0
), where S0 and S correspond to MR voxel intensities at b-
values of 0 s/mm2 and 800 s/mm2. Gross tumor volume (GTV) of the primary tumor was delineated 
by an experienced board-certified oncologist. 
 
Scanner 
model 
Patient 
number 
TR/TE 
(ms) 
Spatial 
resolution 
Field of view 
(cm2) 
Slice 
thickness 
(mm) 
b value (s/mm2) 
Discovery 
MR750 
36 2600/74 256×256 382 or 402 5 0,500,800,1000 
Signa HDxt 7 4500-
6000/64-67 
256×256 322 - 402 5 or 6 0,800 
                                                 Table 1. MR imaging parameters 
 
2.2. Feature extraction 
2.1.1. Handcrafted features  
105 handcrafted features were extracted from the ADC map within the GTV contour for each 
patient using PyRadiomics package (version 2.1.2) [19]. Extracted features consisted of 14 shape-
based features, 18 first-order statistic features, and 73 textural (second-order statistic) features. The 
methods used for extracting textural feature were gray level co-occurrence matrix, gray-level size 
zone matrix, gray level run length matrix, gray level dependence matrix, and neighborhood gray-
tone difference matrix. Shape-based features describe the shape characteristics of the GTV contour. 
First-order statistic features describe the distribution of voxel intensities within the GTV contour. 
Textural features describe the patterns or second-order spatial distributions of the voxel intensities. 
 
2.2.2. DL-based features  
The publicly-available pre-trained CNN, VGG19 [20], was used to extract DL-based features. The 
network was trained using approximately 1.2 million images from the ImageNet database [21] for 
classifying nature images into 1000 objects. Figure 1 shows the network architecture. It contained 
16 convolutional layers followed by 3 fully-connected layers. 5 max-pooling layers were inserted 
across convolutional and fully-connected layers to reduce model parameter number for controlling 
overfitting and help achieve partial invariance to small translations. For each patient, a square 
region of interest (ROI) was selected around the tumor in the transverse slice having the largest 
tumor area. The ROI size was set based on the maximum tumor dimension. The ADC ROI was 
extrapolated to 224 by 224 for matching the original VGG19 design and then input into the pre-
trained model for feature extraction. We adopted the feature extraction method proposed by 
Antropova et al. [16]. As shown in Figure 1, five DL-based feature vectors were extracted by 
average-pooling the feature maps after max-pooling layers. Each feature vector was normalized 
with its Euclidean norm and then concatenated to one feature vector, which was normalized again 
to acquire the feature vector consisting of 1472 features. After extracting features for all patients, 
a cutoff on feature variance was used to select 105 DL-based features with the highest variance.  
 
 
Figure 1. VGG19 architecture and feature extraction scheme. It contained 5 max-pooling layers 
inserting across 16 convolutional layers and 3 fully-connected layers. Feature maps and feature 
vectors, following each layer, are shown as cuboids and rectangles, respectively. The feature map 
depth and feature number are shown. For feature extraction, the network took an ADC ROI as 
input. 1472 DL-based features were extracted from max-pooling feature maps by average-pooling 
along the spatial dimensions. Conv, convolutional layer; ReLu, rectified linear unit. 
 
2.3. Classification and evaluation 
The least absolute shrinkage and selection operator (LASSO) penalized logistic regression [22,23] 
was used for classification using radiomic features (Python version 2.7.13). The LASSO 
regularization was selected to handle the high feature dimension. The handcrafted classifier and 
DL-based classifier were trained using handcrafted features and DL-based features, respectively. 
Regularization parameter was optimized by grid searching with repeated 20 times stratified 4-fold 
cross-validation. For each cross-validation, stratified random sampling was used to split the patient 
cohort was into 4 folds, where 3 folds were used as the training set to train the classifier and the 
remaining one as the testing set for evaluation. 
The performances of the handcrafted and DL-based classifiers were evaluated using the 
average area under the receiver operating curve (AUC) of 20 cross-validation repetitions. The 
corrected resampled t-test [24,25] was conducted to compare the AUC results for two classifiers. 
P-value <0.05 was considered to indicate a significant difference.  
 
3. Results 
3.1. Patient characteristics 
Table 2 summarizes the clinical characteristics of our patient cohort. 22 (51.2%) patients achieved 
GR after nCRT. Among the 22 GR patients, there were 14 (63.6%) men and 8 (36.4%) women. 
Among 21 non-GR patients, there were 14 (66.7%) men and 7 (33.3%) women.  
 
Characteristic GR (n=22) nGR (n=21) Total (n=43) 
Gender (male/female) 14/8 14/7 28/15 
Age (mean, SD, in years) 53.7 (9.1) 54.9 (10.9) 54.3 (10.3) 
Pre-nCRT TNM staging    
T stage (2/3/4) 1/18/3 1/16/4 2/34/7 
N stage (0/1/2) 5/11/6 0/9/12 5/20/18 
Table 2. Patient clinical characteristics; GR, good responder, nGR, non-good responder, SD, 
standard deviation. 
Figure 2 shows the transverse slices of DWIs and ADC maps for the representative GR and 
non-GR patients. Both patients are male with rectal cancer at the same clinical stage of T3N1. No 
significant visual differences were observed.  
 
Figure 2. Comparison of the DWI (b=0,800 s/mm2) slice and the ADC slice for the representative 
GR and non-GR patients. The GTV contours are demonstrated in red. The color bar of the ADC 
slices is shown.  
 
3.2. Classification performance 
Figure 3 (a) compares the boxplots of the mean AUC results of 20 cross-validation repetitions for 
two classifiers. Large deviations were observed due to the small sample size. The AUC of a single 
repetition varies from 0.51 to 0.73 for the handcrafted classifier, and from 0.58 to 0.80 for the DL-
based classifier. The average ROC curves of the two classifiers are shown in Figure 3 (b). The 
handcrafted classifier achieved the mean AUC of 0.64 (standard error [SE], 0.08) using repeated 
20 times 4-fold cross-validation, while the DL-based classifier achieved 0.73 (SE, 0.05). The p-
value of the corrected resampled t-test was 0.049, suggesting a significant difference in the AUC 
results for the handcrafted classifier and DL-based classifier.  
 
Figure 3. (a) Boxplots of the AUC results of 20 cross-validation repetitions for the handcrafted 
and DL-based classifiers. The minimum (bottom line), 25th percentile (bottom of the box), median 
(central line), 75th percentile (top of the box), and maximum (top line) are shown. An outlier is 
drawn as a diamond sign. (b) The ROC curves for two classifiers in predicting good response 
versus non-good response using repeated stratified 4-fold cross-validation. AUC results are 
averaged over 20×4 testing sets. 
 
4. Discussion 
In this study, we compared the performance of the classifiers built with the handcrafted and DL-
based features, extracted from pre-treatment DWI, for predicting the post-nCRT treatment 
response for a cohort of LARC patients. To our knowledge, this is the first study investigating DL-
based features for this application. Compared to the handcrafted features, the DL-based features 
consisted of more abstract high-level information extracted from DWI images. Our study indicated 
that the DL-based classifier achieved a significantly better predictive performance than the 
handcrafted classifier in nCRT response prediction for rectal cancer. Studies showed that the DL-
based features achieved better performance in breast cancer diagnosis and glioblastoma survival 
prediction than the handcrafted features [18,26].  The DL-based features are expected to achieve 
better performance and more generalizable results in diagnosis, recurrence and survival prediction 
for other sites as well.  
We conducted repeated 4-fold cross-validation for evaluating the model performance  as it 
stabilizes the accuracy estimation [25,27]. The handcrafted classifier achieved the mean AUC of 
0.64 for predicting GR vs non-GR, while the DL-based classifier achieved an improved mean AUC 
of 0.73. Additionally, a fused classifier was constructed by averaging prediction scores of two 
classifiers. The fused classifier achieved the mean AUC of 0.71, which is better than that for the 
handcrafted classifier. Nie et al [12], using a single run of 4-fold cross-validation, reported the 
mean AUC of 0.73 for GR and non-GR prediction using DWI handcrafted features on a similar 
size cohort of 48 patients. The standard error of the mean AUC was not reported. To investigate 
the cross-validation variation caused by the different data partitions for a small dataset, we 
conducted 20 independent cross-validation trials using our dataset. It should be noted that 20 
independent cross-validation trials are different from the repeated 20 cross-validation since each 
cross-validation trial has its own optimal hyperparameters, while all 20 cross-validation repetitions 
need to have the same hyperparameters. The mean AUC of each cross-validation trial ranged from 
0.56 to 0.79 for the classifier built with the handcrafted features, and from 0.63 to 0.82 for the one 
built with the DL-based features. Given a relatively small patient size, a single run of cross-
validation may have large bias. Also, different classification models, evaluation protocols, patient 
number, and response label ratio may result in different prediction accuracy. 
We investigated the radiomic features extracted from a single imaging modality of DWI in 
this study. Several studies showed that including the handcrafted features from T2-weighted MR 
images and dynamic contrast-enhanced images improved predictive power [12,13]. The DL-based 
feature extraction scheme can be applied to other MR imaging modalities and may further help 
improve the prediction accuracy. Comparing the handcrafted and DL-based features extracted 
from multiparametric MR images for treatment response prediction would be an interesting study 
to work on in the future.  
Our study has several limitations. First, the study sample is small, which may lead to 
unstable accuracy estimation and suboptimal model performance. A repeated cross-validation 
method was utilized to reduce the bias in the work. LASSO regularization was implemented to 
reduce overfitting. A larger training set may result in better model performance. Second, our 
dataset only contained 9 patients with pathological complete response (pCR). The pCR is defined 
as the absent of viable tumor cells in the primary and lymph nodes. Small number of pCR patients 
and unbalanced labels resulted in large standard deviation on the AUCs using either handcrafted 
features or DL-based features for predicting pCR vs non-pCR. We chose to construct and evaluate 
the predictive model with the classification labels of GR and non-GR in this preliminary study.  A 
larger dataset is desirable to provide the more reliable estimation for the AUC of pCR and non-
pCR prediction. We expect to see better performance from the DL-based features than the 
handcrafted features in predicting pCR on a larger dataset.  
 
5. Conclusion 
Our preliminary study showed that the DL-based features extracted from pretreatment DWIs 
achieved significantly better classification performance for predicting post-nCRT treatment 
response in LARC patients, in comparison to the handcrafted features. Future work involves 
validation with a larger dataset and investigating the predictive power of the DL-based features 
extracted from multiparametric MR images.   
REFERENCE  
[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69:7–34. 
doi:10.3322/caac.21551. 
[2] Kapiteijn E, Marijnen CAM, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. 
Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable 
Rectal Cancer. N Engl J Med 2001;345:638–46. doi:10.1056/NEJMoa010580. 
[3] van de Velde CJH, Boelens PG, Borras JM, Coebergh J-W, Cervantes A, Blomqvist L, et 
al. EURECCA colorectal: Multidisciplinary management: European consensus conference 
colon &amp; rectum. Eur J Cancer 2014;50:1.e1-1.e34. doi:10.1016/J.EJCA.2013.06.048. 
[4] Quah H, Chou JF, Gonen M, Shia J, Schrag D, Saltz LB, et al. Pathologic stage is most 
prognostic of disease‐free survival in locally advanced rectal cancer patients after 
preoperative chemoradiation. Cancer 2008;113:57–64. doi:10.1002/cncr.23516. 
[5] Trakarnsanga A, Gönen M, Shia J, Nash GM, Temple LK, Guillem JG, et al. Comparison 
of Tumor Regression Grade Systems for Locally Advanced Rectal Cancer After 
Multimodality Treatment. JNCI J Natl Cancer Inst 2014;106. doi:10.1093/jnci/dju248. 
[6] Maas M, Nelemans PJ, Valentini V, Das P, Rödel C, Kuo L-J, et al. Long-term outcome 
in patients with a pathological complete response after chemoradiation for rectal cancer: a 
pooled analysis of individual patient data. Lancet Oncol 2010;11:835–44. 
doi:10.1016/S1470-2045(10)70172-8. 
[7] Schurink NW, Lambregts DMJ, Beets-Tan RGH. Diffusion-weighted imaging in rectal 
cancer: current applications and future perspectives. Br J Radiol 2019;92:20180655. 
doi:10.1259/bjr.20180655. 
[8] Beets-Tan RGH, Lambregts DMJ, Maas M, Bipat S, Barbaro B, Curvo-Semedo L, et al. 
Magnetic resonance imaging for clinical management of rectal cancer: Updated 
recommendations from the 2016 European Society of Gastrointestinal and Abdominal 
Radiology (ESGAR) consensus meeting. Eur Radiol 2018;28:1465–75. 
doi:10.1007/s00330-017-5026-2. 
[9] Kim SH, Lee JY, Lee JM, Han JK, Choi BI. Apparent diffusion coefficient for evaluating 
tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal 
cancer. Eur Radiol 2011;21:987–95. doi:10.1007/s00330-010-1989-y. 
[10] Amodeo S, Rosman AS, Desiato V, Hindman NM, Newman E, Berman R, et al. MRI-
Based Apparent Diffusion Coefficient for Predicting Pathologic Response of Rectal 
Cancer After Neoadjuvant Therapy: Systematic Review and Meta-Analysis. Am J 
Roentgenol 2018;211:W205–16. doi:10.2214/AJR.17.19135. 
[11] Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, et al. 
Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin 
Oncol 2017;14:749–62. doi:10.1038/nrclinonc.2017.141. 
[12] Nie K, Shi L, Chen Q, Hu X, Jabbour SK, Yue N, et al. Rectal Cancer: Assessment of 
Neoadjuvant Chemoradiation Outcome based on Radiomics of Multiparametric MRI. Clin 
Cancer Res 2016;22:5256–64. doi:10.1158/1078-0432.CCR-15-2997. 
[13] Horvat N, Veeraraghavan H, Khan M, Blazic I, Zheng J, Capanu M, et al. MR Imaging of 
Rectal Cancer: Radiomics Analysis to Assess Treatment Response after Neoadjuvant 
Therapy. Radiology 2018;287:833–43. doi:10.1148/radiol.2018172300. 
[14] LeCun Y, Bengio Y, Hinton G. Deep learning. Nature 2015;521:436–44. 
doi:10.1038/nature14539. 
[15] Afshar P, Mohammadi A, Plataniotis KN, Oikonomou A, Benali H. From Handcrafted to 
Deep-Learning-Based Cancer Radiomics: Challenges and opportunities. IEEE Signal 
Process Mag 2019;36:132–60. doi:10.1109/MSP.2019.2900993. 
[16] Antropova N, Huynh BQ, Giger ML. A deep feature fusion methodology for breast cancer 
diagnosis demonstrated on three imaging modality datasets. Med Phys 2017;44:5162–71. 
doi:10.1002/mp.12453. 
[17] Wang S, Liu Z, Rong Y, Zhou B, Bai Y, Wei W, et al. Deep learning provides a new 
computed tomography-based prognostic biomarker for recurrence prediction in high-grade 
serous ovarian cancer. Radiother Oncol 2019;132:171–7. 
doi:10.1016/j.radonc.2018.10.019. 
[18] Lao J, Chen Y, Li Z-C, Li Q, Zhang J, Liu J, et al. A Deep Learning-Based Radiomics 
Model for Prediction of Survival in Glioblastoma Multiforme. Sci Rep 2017;7:10353. 
doi:10.1038/s41598-017-10649-8. 
[19] van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, et al. 
Computational Radiomics System to Decode the Radiographic Phenotype. Cancer Res 
2017;77:e104–7. doi:10.1158/0008-5472.CAN-17-0339. 
[20] Simonyan K, Zisserman A. Very deep convolutional networks for large-scale image 
recognition. ArXiv Prepr ArXiv14091556 2014. 
[21] Russakovsky O, Deng J, Su H, Krause J, Satheesh S, Ma S, et al. ImageNet Large Scale 
Visual Recognition Challenge. Int J Comput Vis 2015;115:211–52. doi:10.1007/s11263-
015-0816-y. 
[22] Tibshirani R, Tibshirani R. Regression Shrinkage and Selection Via the Lasso. J R Stat 
Soc Ser B 1994;58:267--288. 
[23] Wu TT, Chen YF, Hastie T, Sobel E, Lange K. Genome-wide association analysis by 
lasso penalized logistic regression. Bioinformatics 2009;25:714–21. 
doi:10.1093/bioinformatics/btp041. 
[24] Nadeau C, Bengio Y. Inference for the Generalization Error. Mach Learn 2003;52:239–
81. doi:10.1023/A:1024068626366. 
[25] Bouckaert RR, Frank E. Evaluating the Replicability of Significance Tests for Comparing 
Learning Algorithms, Springer, Berlin, Heidelberg; 2004, p. 3–12. doi:10.1007/978-3-
540-24775-3_3. 
[26] Antropova N, Huynh BQ, Giger ML. A deep feature fusion methodology for breast cancer 
diagnosis demonstrated on three imaging modality datasets 2017. doi:10.1002/mp.12453. 
[27] Kim J-H. Estimating classification error rate: Repeated cross-validation, repeated hold-out 
and bootstrap. Comput Stat Data Anal 2009;53:3735–45. 
doi:10.1016/J.CSDA.2009.04.009. 
 
